ICP Formulary Updates
|
|
|
- Charles Summers
- 6 years ago
- Views:
Transcription
1 ICP Formulary Updates July 2017 TRADE NAME (generic name) adapalene cream 0.1% Removal adapalene gel 0.3% Removal adefovir dipivoxil tab 10 mg Removal ADVAIR DISKUS (fluticasone-salmeterol aer powder ba mcg/dose) ADVAIR DISKUS (fluticasone-salmeterol aer powder ba mcg/dose) ADVAIR DISKUS (fluticasone-salmeterol aer powder ba mcg/dose) albuterol sulfate tab 2 mg Removal albuterol sulfate tab 4 mg Removal albuterol sulfate tab sr 12hr 4 mg Removal albuterol sulfate tab sr 12hr 8 mg Removal amphetamine-dextroamphetamine cap sr 24hr 5 mg Removal amphetamine-dextroamphetamine cap sr 24hr 10 mg Removal amphetamine-dextroamphetamine cap sr 24hr 15 mg Removal amphetamine-dextroamphetamine cap sr 24hr 20 mg Removal amphetamine-dextroamphetamine cap sr 24hr 25 mg Removal amphetamine-dextroamphetamine cap sr 24hr 30 mg Removal bromocriptine mesylate cap 5 mg (base equivalent) Removal butorphanol tartrate nasal soln 10 mg/ml Removal carbamazepine cap sr 12hr 100 mg Removal carbamazepine cap sr 12hr 200 mg Removal carbamazepine cap sr 12hr 300 mg Removal carbidopa & levodopa orally disintegrating tab mg Removal carbidopa & levodopa orally disintegrating tab mg Removal carbidopa & levodopa orally disintegrating tab mg Removal CEM-UREA (urea soln 45%) ciclopirox olamine susp 0.77% (base equiv) Removal COMPLERA (emtricitabine-rilpivirine-tenofovir df tab mg) CYCLOPHOSPHAMIDE (cyclophosphamide cap 25 mg) Addition Brand CYCLOPHOSPHAMIDE (cyclophosphamide cap 50 mg) Addition Brand DEXEDRINE (Dextroamphetamine sulfate tab 5 mg) DEXEDRINE (Dextroamphetamine sulfate tab 10 mg)
2 dextroamphetamine sulfate cap sr 24hr 5 mg Removal dextroamphetamine sulfate cap sr 24hr 10 mg Removal dextroamphetamine sulfate cap sr 24hr 15 mg Removal dextroamphetamine sulfate tab 5 mg Removal dextroamphetamine sulfate tab 10 mg Removal DULERA (mometasone furoate-formoterol fumarate aerosol mcg/act) DULERA (mometasone furoate-formoterol fumarate aerosol mcg/act) ENDOCET (Oxycodone w/ acetaminophen tab mg) ENTRESTO (sacubitril-valsartan tab mg) Addition Brand ENTRESTO (sacubitril-valsartan tab mg) Addition Brand ENTRESTO (sacubitril-valsartan tab mg) Addition Brand ENVARSUS XR (tacrolimus tab sr 24hr 1 mg) Removal Brand epinastine hcl ophth soln 0.05% Removal EVOTAZ (atazanavir sulfate-cobicistat tab mg (base equiv)) famciclovir tab 125 mg Removal felbamate susp 600 mg/5ml Removal felbamate tab 400 mg Removal felbamate tab 600 mg Removal fentanyl citrate lozenge on a handle 200 mcg Removal fentanyl citrate lozenge on a handle 400 mcg Removal fentanyl citrate lozenge on a handle 600 mcg Removal fentanyl citrate lozenge on a handle 800 mcg Removal fentanyl citrate lozenge on a handle 1200 mcg Removal fentanyl citrate lozenge on a handle 1600 mcg Removal flavoxate hcl tab 100 mg Removal fluoxetine hcl cap 40 mg Removal fluoxetine hcl tab 10 mg Removal fluoxetine hcl tab 20 mg Removal FORTEO (teriparatide (recombinant) inj 600 mcg/2.4ml) FUZEON (enfuvirtide for inj 90 mg) glipizide-metformin hcl tab mg Removal glipizide-metformin hcl tab mg Removal glipizide-metformin hcl tab mg Removal HUMULIN R U-500 (CONCENTRATED) (insulin regular (human) inj 500 unit/ml) HUMULIN R U-500 KWIKPEN (insulin regular (human) soln pen-injector 500 unit/ml) hydrocodone-ibuprofen tab mg Removal
3 hydrocodone-ibuprofen tab mg Removal hydrocodone-ibuprofen tab mg Removal ibandronate sodium tab 150 mg (base equivalent) Removal IBUDONE (Hydrocodone-ibuprofen tab mg) INCRUSE ELLIPTA (umeclidinium br aero powd breath act 62.5 mcg/inh (base eq)) 273 mg/0.875ml) 410 mg/1.315ml) 546 mg/1.75ml) 819 mg/2.625ml) ipratropium bromide nasal soln 0.03% (21 mcg/spray) Removal ipratropium bromide nasal soln 0.06% (42 mcg/spray) Removal KISQALI (ribociclib succinate tab 200 mg (base equiv)) Addition Brand lamotrigine orally disintegrating tab 25 mg Removal lamotrigine orally disintegrating tab 50 mg Removal lamotrigine orally disintegrating tab 100 mg Removal lamotrigine orally disintegrating tab 200 mg Removal lamotrigine tab disp 25 (14) & 50 mg (14) & 100 mg (7) kit Removal lamotrigine tab disp 25 mg (21) & 50 mg (7) titration kit Removal lamotrigine tab disp 50 mg (42) & 100 mg (14) titration kit Removal lamotrigine tab sr 24hr 25 mg Removal lamotrigine tab sr 24hr 50 mg Removal lamotrigine tab sr 24hr 100 mg Removal lamotrigine tab sr 24hr 200 mg Removal lamotrigine tab sr 24hr 250 mg Removal lamotrigine tab sr 24hr 300 mg Removal lansoprazole cap delayed release 15 mg Removal lansoprazole cap delayed release 30 mg Removal malathion lotion 0.5% Removal METADATE ER (Methylphenidate hcl tab cr 20 mg) methadone hcl conc 10 mg/ml Removal METHADONE HCL INTENSOL (Methadone hcl conc 10 mg/ml) methadone hcl soln 5 mg/5ml Removal methadone hcl soln 10 mg/5ml Removal methadone hcl tab 5 mg Removal methadone hcl tab 10 mg Removal methadone hcl tab for oral susp 40 mg Removal
4 METHADOSE (Methadone hcl tab for oral susp 40 mg) METHYLPHENIDATE HCL (methylphenidate hcl chew tab 2.5 mg) METHYLPHENIDATE HCL (methylphenidate hcl chew tab 5 mg) METHYLPHENIDATE HCL (methylphenidate hcl chew tab 10 mg) methylphenidate hcl soln 5 mg/5ml Removal methylphenidate hcl soln 10 mg/5ml Removal methylphenidate hcl tab cr 20 mg Removal morphine sulfate tab cr 15 mg Removal morphine sulfate tab cr 30 mg Removal morphine sulfate tab cr 60 mg Removal morphine sulfate tab cr 100 mg Removal morphine sulfate tab cr 200 mg Removal ODEFSEY (emtricitabine-rilpivirine-tenofovir af tab mg) olopatadine hcl ophth soln 0.1% (base equivalent) Removal omeprazole cap delayed release 10 mg Removal OMNITROPE (somatropin inj 5 mg/1.5ml) OMNITROPE (somatropin inj 10 mg/1.5ml) OPSUMIT (macitentan tab 10 mg) oseltamivir phosphate cap 30 mg (base equiv) Removal oseltamivir phosphate cap 45 mg (base equiv) Removal oseltamivir phosphate cap 75 mg (base equiv) Removal oxycodone w/ acetaminophen tab mg Removal OXYCODONE/IBUPROFEN (oxycodone-ibuprofen tab mg) oxymorphone hcl tab 5 mg Removal oxymorphone hcl tab 10 mg Removal paliperidone tab sr 24hr 1.5 mg Removal paliperidone tab sr 24hr 3 mg Removal paliperidone tab sr 24hr 6 mg Removal paliperidone tab sr 24hr 9 mg Removal PREZCOBIX (darunavir-cobicistat tab mg) rabeprazole sodium ec tab 20 mg Removal repaglinide tab 0.5 mg Removal repaglinide tab 1 mg Removal repaglinide tab 2 mg Removal SELZENTRY (maraviroc tab 150 mg) simvastatin tab 80 mg Removal sotalol hcl (afib/afl) tab 80 mg Removal
5 sotalol hcl (afib/afl) tab 120 mg Removal sotalol hcl (afib/afl) tab 160 mg Removal SPIRIVA RESPIMAT (tiotropium bromide monohydrate inhal aerosol 1.25 mcg/act) STRATTERA (atomoxetine hcl cap 10 mg (base equiv)) STRATTERA (atomoxetine hcl cap 18 mg (base equiv)) STRATTERA (atomoxetine hcl cap 25 mg (base equiv)) STRATTERA (atomoxetine hcl cap 40 mg (base equiv)) STRATTERA (atomoxetine hcl cap 60 mg (base equiv)) STRATTERA (atomoxetine hcl cap 80 mg (base equiv)) STRATTERA (atomoxetine hcl cap 100 mg (base equiv)) STRIBILD (elvitegrav-cobic-emtricitab-tenofovdf tab mg) SYNAGIS (palivizumab im soln 50 mg/0.5ml) Removal Brand SYNAGIS (palivizumab im soln 100 mg/ml) Removal Brand TAMIFLU (oseltamivir phosphate for susp 6 mg/ml (base equiv)) Removal Brand TAZORAC (tazarotene cream 0.05%) tiagabine hcl tab 2 mg Removal tiagabine hcl tab 4 mg Removal tolcapone tab 100 mg Removal tramadol-acetaminophen tab mg Removal TRIUMEQ (abacavir-dolutegravir-lamivudine tab mg) UPTRAVI (selexipag tab 200 mcg) UPTRAVI (selexipag tab 400 mcg) UPTRAVI (selexipag tab 600 mcg) UPTRAVI (selexipag tab 800 mcg) UPTRAVI (selexipag tab 1000 mcg) UPTRAVI (selexipag tab 1200 mcg) UPTRAVI (selexipag tab 1400 mcg) UPTRAVI (selexipag tab 1600 mcg) valganciclovir hcl for soln 50 mg/ml (base equiv) Removal XTANDI (enzalutamide cap 40 mg) Addition Brand ZENZEDI (Dextroamphetamine sulfate tab 5 mg) ZENZEDI (Dextroamphetamine sulfate tab 10 mg) A division of Health Care Service Corporation, a Mutual Legal Reserve Company, an independent Licensee of the Blue Cross Blue Shield Association. Blue Cross and Blue Shield of Illinois (BCBSIL) contracts with Prime Therapeutics to provide pharmacy benefit management, home delivery pharmacy services and specialty pharmacy services. BCBSIL, as well as several other independent Blue Cross and Blue Shield Plans, has an ownership interest in Prime Therapeutics LLC N IL Prime Therapeutics LLC 07/17
6 Blue Cross and Blue Shield of Illinois complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. Blue Cross and Blue Shield of Illinois does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. Blue Cross and Blue Shield of Illinois: Provides free aids and services to people with disabilities to communicate effectively with us, such as: Qualified sign language interpreters Written information in other formats (large print, audio, accessible electronic formats, other formats) Provides free language services to people whose primary language is not English, such as: Qualified interpreters Information written in other languages If you need these services, contact Civil Rights Coordinator. If you believe that Blue Cross and Blue Shield of Illinois has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Civil Rights Coordinator, Office of Civil Rights Coordinator, 300 E. Randolph St., 35 th floor, Chicago, Illinois 60601, , TTY/TDD: , Fax: , Civilrightscoordinator@hcsc.net. You can file a grievance in person or by mail, fax, or . If you need help filing a grievance, Civil Rights Coordinator is available to help you. You can also file a civil rights complaint with the U.S. Department of Health and Human Services, Office for Civil Rights, electronically through the Office for Civil Rights Complaint Portal, available at or by mail or phone at: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C , (TDD) Complaint forms are available at A Division of Health Care Service Corporation, a Mutual Legal Reserve Company, an Independent Licensee of the Blue Cross and Blue Shield Association IL_MEDICAID_MLI_ Approved
7
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates July 2018 TRADE NAME (generic name) or generic name ADVAIR DISKUS (fluticasone-salmeterol aer powder ba 100-50 mcg/dose) Brand Addition ADVAIR
AVMED 4 TIER AND 5 TIER FORMULARY QUANTITY LIMIT TABLE
Effective 4/1/2018 AVMED 4 TIER AND 5 TIER FORMULARY QUANTITY LIMIT TABLE Generic Name Brand Name Quantity Limit Description Comments ABACAVIR SOLN 20 MG/ML ZIAGEN 900ml every 30 days ABACAVIR TAB 300
2014 Quantity Limits (QL) Criteria
2014 Quantity Limits (QL) Criteria Certain drugs covered through your EmblemHealth Medicare HMO/PPO Medicare Plan are covered for only a limited quantity. We do this to ensure compliance with the US Food
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates April 2018 TRADE NAME (generic name) or generic name Brand/Generic Description of Change abacavir sulfate soln 20 mg/ml (base equiv) Generic
Aetna Better Health of Illinois Medicaid Formulary Updates
October 2017 o DOXYLAMINE SUCCINATE 25mg-QL o DULOXETINE CAP 40MG DR-QL o GUANFACIN ER TABS (all strengths)-ql o TOBRAMYCIN NEBU SOLUTION- PA August 2017 Aetna Better Health of Illinois Medicaid 2017 Formulary
Pharmacy Program Updates: Quarterly Pharmacy Changes Effective July 1, 2017
Pharmacy Program Updates: Quarterly Pharmacy Changes Effective July 1, 2017 DRUG LIST CHANGES Based on the availability of new prescription medications and Prime s National Pharmacy and Therapeutics Committee
Santa Clara Family Health Plan Cal MediConnect Plan (Medicare-Medicaid Plan) 2017 Drug List
Upcoming Changes to Santa Clara Family Health Plan Cal MediConnect Plan (Medicare-Medicaid Plan) 2017 Drug List Updated 8/1/2017 Santa Clara Family Health Plan (SCFHP) Cal MediConnect Plan (Medicare-Medicaid
CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.
ADHD STIMULANTS ATOMOXETINE HCL, DEXEDRINE 10 MG TABLET, DEXEDRINE 5 MG TABLET, DEXMETHYLPHENIDATE HCL, DEXMETHYLPHENIDATE HCL ER, DEXTROAMPHETAMINE 10 MG TAB, DEXTROAMPHETAMINE 5 MG TAB, DEXTROAMPHETAMINE
2014 Step Therapy Criteria (List of Step Therapy Criteria)
Criteria Last Updated: November 1, 2014 2014 Step Therapy Criteria (List of Step Therapy Criteria) PLEASE READ CAREFULLY: IEHP MEDICARE DUALCHOICE (HMO SNP) REQUIRES YOU TO FIRST TRY CERTAIN DRUGS TO TREAT
Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir
Acyclovir Ointment Mercy Care Plan acyclovir ointment 5 % external Requires use of oral Acyclovir 1 Adcirca ADCIRCA TABLET 20 MG ORAL Requires use of Sildenafil 2 Albenza ALBENZA TABLET 200 MG ORAL Requires
2017 Formulary Changes Year to Date
2017 Formulary Changes Year to Date Health Choice Arizona may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, add prior authorization, quantity limits and/or
Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria
ALBENDAZOLE Mercy Care ALBENZA TABLET 200 MG ORAL Refer to PA Guideline for approval criteria 1 BRIMONIDINE-TIMOLOL COMBIGAN SOLUTION 0.2-0.5 % OPHTHALMIC Requires use of separate ingredients for at least
2019 Drug List Negative Changes
2019 Drug List Negative Changes Updated 03/26/2019 If you are taking a drug that is removed from the formulary (also known as the Drug List), we will tell you. We will also tell you if we add any restrictions
Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria
Medications that require Step Therapy (ST) require trial and failure of preferred formulary agents prior to their authorization. If the prerequisite medications have been filled within the specified time
AETNA BETTER HEALTH January 2017 Formulary Change(s)
AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on February 1, 2017 Drug Name, Strength, Dosage Form IVERMECTIN 3 MG TABLET
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand
2019 Drug List Negative Changes
2019 Drug List Negative Changes Updated 03/26/2019 If you are taking a drug that is removed from the formulary (also known as the Drug List), we will tell you. We will also tell you if we add any restrictions
AETNA BETTER HEALTH January 2017 Formulary Change(s)
AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on March 1, 2017 Drug Name, Strength, Dosage Form ALFUZOSIN HCL ER 10
TennCare Program TN MAC Price Change List As of: 03/30/2017
1 TN List Run : 03/30/17 Old PRAZOSIN HCL 5 MG CAPSULE ORAL 03/29/2017 1.11209 1.12560 ( 1.2) CAPTOPRIL 12.5 MG TABLET ORAL 07/07/2015 1.07191 1.10416 ( 2.9) ISOSORBIDE DINITRATE 5 MG TABLET ORAL 03/29/2017
APOKYN (apomorphine hydrochloride)
APOKYN (apomorphine hydrochloride) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices
Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions
Alameda Alliance for Health FORMULARY UPDATE Effective: April 21, 2017. Drugs notated with an * have an undetermined implementation date Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee
2018 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York 2018 Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January 2018. This
Quantity Limits 2016 Paramount Medicare Formulary Formulary ID: Version 26 Updated: 11/1/2016
Quantity Limits 2016 Paramount Medicare Formulary Formulary ID: 16162 Version 26 Updated: 11/1/2016 ANALGESICS acetaminophen w/ codeine (300-15 mg, 300-30 mg, 300-60 mg) acetaminophen w/ codeine soln 120-12
MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 03/07/18 SECTION: DRUGS LAST REVIEW DATE: 02/19/19 LAST CRITERIA REVISION DATE: ARCHIVE DATE:
FUZEON (enfuvirtide) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
PANCREATIC ISLET TRANSPLANT
PANCREATIC ISLET TRANSPLANT Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices
ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019
Step Therapy Date Effective: April 1, 2019 ANTICONVULSANTS APTIOM TABLET 200 MG ORAL APTIOM TABLET 400 MG ORAL APTIOM TABLET 600 MG ORAL APTIOM TABLET 800 MG ORAL BANZEL SUSPENSION 40 MG/ML ORAL BANZEL
BlueLink TPA FlexRx Updates
BlueLink TPA FlexRx Updates April 2018 TRADE NAME (generic name) or generic name abacavir sulfate soln 20 mg/ml (base equiv) Generic Addition, generic for ZIAGEN alclometasone dipropionate cream 0.05%
2018 Preventive Schedule
2018 Preventive Schedule Medicare-Covered Services PLAN YOUR CARE: KNOW WHAT YOU NEED AND WHEN TO GET IT Preventive or routine care helps us stay well or finds problems early, when they are easier to treat.
HEMATOPOIETIC CELL TRANSPLANTATION FOR EPITHELIAL OVARIAN CARCINOMA
CARCINOMA Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are dependent
Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies
Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies BlueCross BlueShield of South Carolina may add or remove drugs from the formulary during the year. If we remove drugs
GENETIC TESTING FOR PREDICTING RISK OF NONFAMILIAL BREAST CANCER
Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are dependent upon
ENDOBRONCHIAL ULTRASOUND FOR DIAGNOSIS AND STAGING OF LUNG CANCER
CANCER Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are dependent
Step Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 12/01/2017 Updated 11/2017 H0302_2_2014 CMS Accepted 05/05/2014 1 ABILIFY Abilify 10 mg tablet
Step Therapy Medications
Step Therapy Medications Step Therapy Group APTIOM Step-2: APTIOM 200 MG TABLET or APTIOM 400 MG TABLET or APTIOM 600 MG TABLET or APTIOM 800 MG TABLET Step 1 Drug(s): Oxcarbazepine immediate-release,
Step Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 05/01/2018 Updated 4/2018 H0302_2_2014 CMS Accepted 05/05/2014 1 BETA-BLOCKERS BYSTOLIC 10 MG
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand
IMMUNE CELL FUNCTION ASSAY
IMMUNE CELL FUNCTION ASSAY Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and
MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 07/05/18 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:
CINQAIR (reslizumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
Drug List Oregon (OR) This formulary was updated on April 22, 2018.
8 Oregon (OR) Drug List This formulary was updated on April, 8. Please Read: This document contains information about the drugs we cover in this plan. For a complete, up-to-date list of covered drugs,
Calendar Year Deductible Annual Benefit Maximum. ADA Code Covered Services Member pays. n/a Office visit $5 per visit
Blue Shield of California Dental HMO Plan Dental HMO Basic Benefit summary Effective January 1, 2018 THIS MATRIX IS INTENDED TO BE USED TO HELP YOU COMPARE COVERAGE BENEFITS AND IS A SUMMARY ONLY. THE
TYMLOS (abaloparatide)
TYMLOS (abaloparatide) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
PDP Classic Formulary Addendum
PDP Classic Formulary Addendum The following medications have been added to the WellCare formulary as of March 2009. Drug Name Therapeutic Class Drug Tier Requirements/Limits Changes Made acetazolamide
DRUG TESTING IN PAIN MANAGEMENT AND SUBSTANCE USE DISORDER(S) TREATMENT
TREATMENT Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are dependent
Department of Origin: Integrated Healthcare Services. Approved by: Chief Medical Officer Department(s) Affected: Date approved: 01/10/17
Reference #: MP/D005 Page: 1 of 3 PRODUCT APPLICATION: PreferredOne Administrative Services, Inc. (PAS) ERISA PreferredOne Administrative Services, Inc. (PAS) Non-ERISA PreferredOne Community Health Plan
THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM
Value Based Tier Drugs are selected for the management of Asthma, Diabetes, Hypertension and Hyperlipidemia. These drugs are covered at no charge or at a reduced cost share. Medications are under continual
LARTRUVO (olaratumab)
LARTRUVO (olaratumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
Smile SM Value 50/1500/No Ortho/MAC
Blue Shield of California Dental PPO Plan Smile SM Value 50/1500/No Ortho/MAC Benefit summary Effective January 1, 2018 THIS MATRIX IS INTENDED TO BE USED TO HELP YOU COMPARE COVERAGE BENEFITS AND IS A
Quarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice The formulary changes listed in the table below were reviewed and approved at our second quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October
Michigan Department of Community Health Quantity Limitations
Abstral (fentanyl) sl tab all strength Acetaminophen Actonel Actonel 35mg Adderall XR 5mg, 10mg, 15mg 240 per 34 days 3 gm/day 2 every 28 days 4 every 28 days Advair Diskus. No more than 180 every 30 days
GENETIC TESTING FOR TAMOXIFEN TREATMENT
GENETIC TESTING FOR TAMOXIFEN TREATMENT Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical
2018 Formulary Notice of Change Prescription Drug Plans
2018 Formulary Notice of Change Prescription Drug Plans WellCare Prescription Insurance, Inc. Plans in all states: WellCare Classic (PDP) WellCare may add or remove drugs from our formulary during the
Alprazolam 0.25mg, 0.5mg, 1mg tablets
Presbyterian Senior Care (HMO) / Presbyterian MediCare PPO Quantity Limits Effective November 1, 2014 For the most recent list of drugs or other questions, please contact the Presbyterian Customer Service
Aetna Better Health FIDA Plan
Aetna Better Health FIDA Plan May 2016 Formulary Updates ASCOMP/COD - QL; PA FYAVOLV 5MCG; 1MG- PA METOPROLOL TABS 37.5MG, 75MG CIPRODEX LETAIRIS - QL; PA OFEV - QL; PA OTREXUP - ST PRALUENT - QL; PA RASUVO
HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily
HIV MEDICATIONS AT A GLANCE Generic Name Trade Name Strength DIN Usual Dosage Single Tablet Regimen (STR) Products Efavirenz/ Emtricitabine/ rilpivirine/ elvitegravir/ cobicistat/ alafenamide Emtricitabine/
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary October 1, 2018 Updates. Formulary. Alternatives
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select October 1, 2018 Updates Drug Name efavirenz 600mg (Brand = Sustiva ) trientine (Brand = Syprine ) hydrocortisone lot 0.1% (Brand = Locoid ) sumatriptan-naproxen
Formulary (Drug List)
Formulary (Drug List) PacificSource Community Solutions This list was updated on /5/07 Please Read: This document contains information about the drugs we cover on this plan. For a complete, up-to-date
Updates to your prescription benefits
Updates to your prescription benefits Effective Jan. 1, 2018 Update Summary Within the Prescription Drug List (PDL), medications are grouped by tier. The tier indicates the amount you pay when you fill
ALPHA1-PROTEINASE INHIBITORS
ALPHA1-PROTEINASE INHIBITORS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices
2018 Step Therapy Criteria (List of Step Therapy Criteria)
Step Therapy Criteria Last Updated: March 20, 2018 Effective Date: April 1, 2018 2018 Step Therapy Criteria (List of Step Therapy Criteria) PLEASE READ CAREFULLY: IEHP DUALCHOICE CAL MEDICONNECT PLAN (MEDICARE-MEDICAID
Smile SM Deluxe Gold 50/1500/Ortho/U85
Blue Shield of California Dental PPO Plan Smile SM Deluxe Gold 50/1500/Ortho/U85 Benefit summary Effective January 1, 2017 THIS MATRIX IS INTENDED TO BE USED TO HELP YOU COMPARE COVERAGE BENEFITS AND IS
Quarterly pharmacy formulary change notice
MEDICAID PROVIDER BULLETIN October 2018 The formulary changes listed in the table below were reviewed and approved at the second-quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October
THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM
Value Based Tier Drugs are selected for the management of Asthma, Diabetes, Hypertension and Hyperlipidemia. These drugs are covered at no charge or at a reduced cost share. Medications are under continual
MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 10/04/17 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:
BAVENCIO (avelumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
Quarterly pharmacy formulary change notice
Provider Bulletin October 2018 Quarterly pharmacy formulary change notice The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus patients. The changes listed in the table
Health Partners Medicare Prime 2019 Formulary Changes
Health Partners Medicare Prime 2019 Formulary Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes
GENETIC TESTING FOR KRAS, NRAS AND BRAF VARIANT ANALYSIS IN METASTATIC COLORECTAL CANCER
METASTATIC COLORECTAL CANCER Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices
MOLECULAR TESTING IN THE MANAGEMENT OF PULMONARY NODULES
MOLECULAR TESTING IN THE MANAGEMENT OF PULMONARY NODULES Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services,
2016 Allegian Choice Preferred Drug List (formulary)
2016 Allegian Choice Preferred Drug List (formulary) The Allegian Choice Formulary is a list of drugs covered by Allegian Health Plans, Inc. for its Allegian Choice plans. The drug list is updated often
RADIOFREQUENCY ABLATION OF PRIMARY OR METASTATIC LIVER TUMORS
Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are dependent upon
Pequot Health Care Opioid Analgesic Quantity Program*
Pequot Health Care 1 Annie George Drive Mashantucket, CT 06338 Phone: 1-888-779-6638 Fax: 1-860-396-6494 Pequot Health Care Opioid Analgesic Quantity Program* Effective January 2018 *Quantity Program limits
Calendar Year Deductible Annual Benefit Maximum. ADA Code Covered Services Member pays
An independent member of the Blue Shield Association A50861-SG (1/19) Dental HMO Plan Dental HMO Standard Benefit summary Effective January 1, 2019 THIS MATRIX IS INTENDED TO BE USED TO HELP YOU COMPARE
ORAL IMPLANT PROCEDURES
ORAL IMPLANT PROCEDURES Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and
Part D Pharmacy. An Independent Licensee of the Blue Cross Blue Shield Association ( )
Part D Pharmacy 1 An Independent Licensee of the Blue Cross Blue Shield Association 044507 (12-21-2017) New MA pharmacy partner We ve selected CVS Caremark to manage our part D pharmacy benefits Providence
Quarterly pharmacy formulary change
Medi-Cal Managed Care L. A. Care Major Risk Medical Insurance Program Provider Bulletin The formulary changes listed in the table below were reviewed and approved at our first-quarter 2018 Pharmacy and
TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder
TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific
ENTYVIO (vedolizumab)
ENTYVIO (vedolizumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
Smile SM Plus 50/1500/Ortho/MAC
Dental PPO Plan Smile SM Plus 50/1500/Ortho/MAC Benefit summary Effective January 1, 2019 THIS MATRIX IS INTENDED TO BE USED TO HELP YOU COMPARE COVERAGE BENEFITS AND IS A SUMMARY ONLY. THE EVIDENCE OF
OHIO MEDICAID PHARMACY COVERAGE
OHIO MEDICAID PHARMACY COVERAGE This information is intended for use by providers to help select the most appropriate cost-effective medication and formulation for their patients. Prescribers should utilize
Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017)
Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017) The Capital BlueCross formulary is a reference list of prescription drugs that contains a wide range of generic and brand drugs that have
TREATMENTS FOR GAUCHER DISEASE
TREATMENTS FOR GAUCHER DISEASE Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices
PROTEOMIC TESTING FOR SYSTEMIC THERAPY IN NON-SMALL-CELL LUNG CANCER
CANCER Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are dependent
WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum
WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum This is a listing of the changes that have occurred in our formulary. Please carefully review these changes and call WellCare if you
Step Therapy Requirements. Effective: 11/01/2018
Effective: 11/01/2018 Updated 10/2018 ANTIDEPRESSANTS Sharp Health Plan (HMO) TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK
CIMZIA (certolizumab pegol)
CIMZIA (certolizumab pegol) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices
A flu shot could save a life
September 2017 Health and wellness or prevention information A flu shot could save a life The flu shot is the best protection from the flu, for you and the people around you. 1. It can help you not get
Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*
Allergy Chlorpheniramine Tablet* Diphenhydramine Tablet* Diphenhydramine Liquid* Loratadine Tablet* Cetirizine Tablet* Loratadine 10mg ODT* Less than $10 Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*
RELISTOR (methylnaltrexone bromide) INJECTION FOR SUBCUTANEOUS USE
RELISTOR (methylnaltrexone bromide) INJECTION FOR SUBCUTANEOUS USE Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for
STELARA (ustekinumab)
STELARA (ustekinumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
August 2016 Formulary Updates
August 2016 Formulary Updates DOXYCYCLINE HYCLATE TABS DR 50MG, 200MG NALOXONE HCL INJ 0.4MG/ML VANCOMYCIN HCL INJ 500MG, 750MG BRIVIACT INJ - PA BRIVIACT ORAL SOLN - QL; PA BRIVIACT TABS - QL; PA LENVIMA
BRINEURA (cerliponase alfa)
BRINEURA (cerliponase alfa) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices
Removed from formulary. Removed from formulary. Added to formulary. Quanitity limit changed. Removed from formulary. Removed from formulary
AETNA BETTER HEALTH October 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on October 1, 2017 MIDAZOLAM HCL 5MG/ML VIAL MIDAZOLAM HCL 10 MG/2 ML
BLINCYTO (blinatumomab)
BLINCYTO (blinatumomab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and
INTRAPERITONEAL CHEMOTHERAPY, CYTOREDUCTION
INTRAPERITONEAL CHEMOTHERAPY, CYTOREDUCTION Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures,
MYLOTARG (gemtuzumab ozogamicin)
MYLOTARG (gemtuzumab ozogamicin) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices
University System of Georgia Prior Authorization, Step Therapy and Quantity Limit List (Updated 1/1/2016)
University System of Georgia, Step Therapy and Quantity Limit List (Updated 1/1/2016) (PA) Your doctor will need to obtain a prior authorization for the drugs listed below, before your prescription drug
TABLE OF CONTENTS (Click on a link below to view the section.)
Follow the links below to access the complete formularies for Plans: Health Plan Acne Allergy Allergic Anaphylactic Reaction Allergic Conjunctivitis Allergic Rhinitis Asthma Atopic Dermatitis Behavioral